Prospective randomised study of PBSC mobilisation using intermediate dose cyclophosphamide and G-CSF versus G-CSF alone.

被引:0
|
作者
Karanth, M
Harvey, C
Chakrabarti, S
Holder, K
McConkey, CC
McDonald, D
Lovell, RA
Fegan, CD
Milligan, DW
机构
[1] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England
[2] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham B15 2TT, W Midlands, England
[3] Univ Birmingham, Birmingham Ctr, Natl Blood Serv, Birmingham B15 2TT, W Midlands, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3261
引用
收藏
页码:826A / 826A
页数:1
相关论文
共 50 条
  • [21] COMPARISON OF HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF WITH G-CSF ALONE FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION IN MM
    Jang, J. E.
    Hyun, S. Y.
    Hwang, D. Y.
    Yoon, S. H.
    Kim, Y. D.
    Kim, S. J.
    Kim, J. S.
    Cheong, J. -W.
    Min, Y. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 83 - 83
  • [22] PBPC mobilization with G-CSF alone in patients failing with chemotherapy and G-CSF
    Fraipont, V
    Sautois, B
    Baudoux, E
    Fassotte, MF
    Jerusalem, G
    Hermanne, JP
    Longrée, L
    Schaaf-Lafontaine, N
    Sondag, D
    Fillet, G
    Beguin, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 70 - 70
  • [23] High-Dose Cyclophosphamide In Combination With G-CSF Versus G-CSF Alone For Mobilization Of Hematopoietic Stem Cells After Induction Therapy Including Velcade, Cyclophosphamide and Dexacort
    Benyamini, Noam
    Avivi, Irit
    Dann, Eldad J.
    Zuckerman, Tsila
    Noa, Lavi
    Katz, Tami
    BLOOD, 2013, 122 (21)
  • [24] Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies
    F Awan
    S T Kochuparambil
    D E Falconer
    A Cumpston
    S Leadmon
    K Watkins
    D DeRemer
    A Jillella
    M Craig
    M Hamadani
    Bone Marrow Transplantation, 2013, 48 : 1279 - 1284
  • [25] Increased Efficacy of Chemomobilization with Intermediate Dose Cytarabine plus G-CSF Compared to G-CSF Alone for Patients with Multiple Myeloma: Results of a Prospective, Randomized Trial
    Czerw, Tomasz
    Mendrek, Wlodzimierz
    Najda, Jacek
    Sobczyk-Kruszelnicka, Malgorzata
    Sadus-Wojciechowska, Maria
    Soska, Katarzyna
    Glowala-Kosinska, Magdalena
    Chwieduk, Agata
    Fidyk, Wojciech
    Holowiecki, Jerzy
    Giebel, Sebastian
    BLOOD, 2016, 128 (22)
  • [26] Etoposide (VP-16)+G-CSF mobilizes different dendritic cell subsets than does G-CSF alone.
    Bolwell, BJ
    Sobecks, R
    Pohlman, B
    Andresen, S
    Bell, K
    Bernhard, L
    Koennecke, J
    Serafino, S
    Ostendorf, H
    Theil, K
    Kuczkowski, E
    Rybicki, L
    Jarvis, J
    Kalaycio, M
    BLOOD, 2001, 98 (11) : 180A - 180A
  • [27] G-CSF plus SCF significantly increases quantity and quality of primitive progenitors in mobilized blood compared with G-CSF alone.
    Lamming, CE
    Verfaillie, CM
    BLOOD, 2000, 96 (11) : 519A - 519A
  • [28] RESPONSE TO INDUCTION TREATMENT ADAPTED SELECTION OF MOBILIZATION REGIMEN IN MULTIPLE MYELOMA: THE G-CSF ALONE VERSUS HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF REGIMEN
    Lee, J. Y.
    Kim, S. J.
    Jang, J. E.
    Suh, C.
    Lee, H.
    Yhim, H. Y.
    Lee, W. S.
    Min, C. K.
    Lee, J. H.
    Kim, J. S.
    HAEMATOLOGICA, 2014, 99 : 647 - 648
  • [29] RESPONSE TO INDUCTION TREATMENT ADAPTED SELECTION OF MOBILIZATION REGIMEN IN MULTIPLE MYELOMA: THE G-CSF ALONE VERSUS HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF REGIMEN
    Jungyeon, L.
    Jeong, K. Soo
    Eun, J. Ji
    Chelwon, S.
    Hyewon, L.
    Ho-Young, Y.
    Sik, L. Won
    Chang-Ki, M.
    Hoon, L. Jae
    Seok, K. Jin
    BONE MARROW TRANSPLANTATION, 2014, 49 : S525 - S526
  • [30] Intermediate dose etoposide plus G-CSF 16 μg/kg is more effective than cyclophosphamide 4 g/m2 plus G-CSF 10 μg/kg in PBSC mobilization of lymphoma patients
    Milone, Giuseppe
    Leotta, Salvatore
    Battiato, Katia
    Murgano, Pamela
    Mercurio, Salvatore
    Strano, Aurora
    Poidomani, Massimo
    Coppoletta, Stefania
    Mauro, Elisa
    Avola, Giuseppe
    Pinto, Valeria
    Camuglia, Maria Grazia
    Giustolisi, Rosario
    LEUKEMIA & LYMPHOMA, 2007, 48 (10) : 1950 - 1960